SPRINGFIELD – State Senator Mike Halpin passed legislation through the Senate that limits the cost of Epinephrine Auto-Injectors, commonly known by the brand name EpiPens, to a maximum of $60 per twin-pack.

"No household should have to decide between buying life-saving medication and providing food for their family," said Halpin (D-Rock Island). "This legislation marks a significant stride towards enhancing the affordability and accessibility of EpiPens for all Illinoisans who require them."

Epinephrine Auto-Injectors are the only medication that works on the entire body to combat anaphylaxis, a potentially fatal allergic reaction. However, since 2017, a global shortage of these devices has made this medication increasingly difficult to obtain. Parts of the United States have experienced shortages since 2018, with the FDA permitting an extension of the recommended shelf life of EpiPens to combat the shortage.

In addition to the shortage, the cost of EpiPens has skyrocketed in recent years, with a twin pack costing anywhere from $500-700 on average, and a single injector costing anywhere from $300-400. This has placed a significant financial burden on families who need to keep multiple EpiPens on hand for emergencies.

“This achievement is a significant win for households who are facing difficulties in purchasing this medication that can save lives,” said Halpin. “It's high time to put an end to excessive corporate profits. People's ability to come up with $500 dollars shouldn't be the deciding factor in determining whether they can access life-saving medication.”

House Bill 3639 passed the Senate on Wednesday and heads to the governor’s desk for final approval.